| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |